BORTEZOMIB FOR INJECTION

Google image searchProduct monograph

Active ingredient

bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02423405

Dosage form(s): POWDER FOR SOLUTION

Route(s) of administration: INTRAVENOUS, SUBCUTANEOUS

Schedule: Prescription

Company: TEVA CANADA LIMITED

Date: 20-MAY-2015

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XG — Proteasome inhibitors (ATC, ATC/DDD)
• L01XG01 — BORTEZOMIB (ATC/DDD)

Reference brand drug: Velcade

Pharmaceutical standard: MFR

External Links for Bortezomib For Injection

Search on Google

• Bortezomib For Injection side effects
• Bortezomib For Injection dosage
• bortezomib side effects
• bortezomib dosage

Teva Canada Limited

Go to Teva website to see drug product details. Sometimes you can find bortezomib for injection photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.